Windlas Biotech informs about board meeting
Windlas Biotech has informed that a meeting of the Board of Directors of the Company will be held on April 17, 2026, inter-alia, to consider and approve the proposal for buyback of its fully paid-up equity shares of the company and the matters necessary and incidental thereto, in accordance with the applicable provisions of the Companies Act, 2013, including rules framed thereunder, the Securities and Exchange Board of India (Buy-Back of Securities) Regulations, 2018, as amended, and other applicable laws.
The above information is a part of company’s filings submitted to BSE.
